Veterinary Diclazuril Oral Solution 1% for Animal Health

Name: Veterinary Diclazuril Oral Solution 1% for Animal Health
Brand: Henan Chuangxin Biological Technology Co., Ltd.
SKU: 1942293365

Henan, ChinaHenan Chuangxin Biological Technology Co., Ltd.

Negotiable

10,000 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Varieties

Growth Promoting Medicine

Component

Botany

Type

The First Class

Pharmacodynamic Influential Factors

Animal Species

Storage Method

Prevent High or LowTemperature

Veterinary Reg. No.

(2018) Veterinary Drug Production Certificate No.

Specification

100ml orcustomized

Trademark

CHBT

Origin

Henan China

Company profile

Self-brandedPatents AwardedFlexible CustomizationQuality Assurance

Henan Chuangxin Biological Technology Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 5years CertifiedNearest Port: Shanghai Port, Shenzhen PortAverage Response Time: ≤3.83h

AI-Powered supplier vetting

SummaryHenan Chuangxin Biological Technology Co., Ltd. is a China-based manufacturing company in animal pharmaceuticals, with stated research, production, sales, and after-sales activities. Evidence shows multiple specialized facilities, in-stock capacity, export activity, documented finished-product inspection, and broad customization, ODM, and OEM capabilities. However, the supplier reports no new products in the past year, no 3D software design, no quality-control test equipment, no valid manufacturing-capacity contract with related subcontractors, and limited documentation for some service-management procedures. The provided information does not establish certifications, specific customer cases, or sufficient financial credibility.

Supplier typeThe supplier is identified as a factory and a combined company in Henan, China, operating in health and medicine and chemicals. Its stated business integrates animal-drug R&D, manufacturing, sales, and after-sales service, with products including ivermectin, veterinary medicine, and enrofloxacin injection.

After-Sales capabilityThe company explicitly describes after-sales service as part of its operations, and technology engineers provide technical support for production and after-sales service. Customer complaints have a clear procedure with followed records, although the broader effective-service assessment and corrective-action process lack records.

R&D capabilityThe supplier has five R&D engineers whose responsibilities include confirming requirements, designing products, and providing technical support, and it offers ODM services. Nevertheless, it reports no new products in the past year, no 3D software design services, and no available SDK, indicating limitations in documented recent innovation and digital design capability.

Production capacityThe supplier reports formulating, filling, sterile, feeding, mixture, and packing facilities, a 6,605.0 m² manufacturing plant, in-stock capacity, and uniformly followed finished-product inspection instructions. Production-related weaknesses include zero quality-control test equipment reported and no valid contract with related subcontractors for manufacturing capacity.

Customization capabilityThe supplier explicitly offers customization from samples and designs, full, minor, and flexible customization, as well as ODM and OEM services for popular brands. This is direct evidence of broad customization capability, despite the separate lack of 3D software design services.